Pende D - Search Results

1

Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96.

Pilla L, Squarcina P, Coppa J, Mazzaferro V, Huber V, Pende D, Maccalli C, Sovena G, Mariani L, Castelli C, Parmiani G, Rivoltini L. Pilla L, et al. Among authors: pende d. Cancer Res. 2005 May 1;65(9):3942-9. doi: 10.1158/0008-5472.CAN-04-3493. Cancer Res. 2005. PMID: 15867395

2

Existence of a natural killer (NK) cell repertoire for (allo)antigen recognition: definition of five distinct NK-determined allospecificities in humans.

Moretta L, Ciccone E, Pende D, Viale O, Di Donato C, Tripodi G, Orengo AM, Guardiola J, Moretta A. Moretta L, et al. Among authors: pende d. Pharmacol Res. 1992 Sep;26 Suppl 2:98-9. doi: 10.1016/1043-6618(92)90616-j. Pharmacol Res. 1992. PMID: 1409338 No abstract available.

3

Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells.

Moretta A, Ciccone E, Tambussi G, Bottino C, Viale O, Pende D, Santoni A, Mingari MC. Moretta A, et al. Among authors: pende d. Int J Cancer Suppl. 1989;4:48-52. doi: 10.1002/ijc.2910440713. Int J Cancer Suppl. 1989. PMID: 2478490 Review.

4

Phenotypic and functional analysis of human CD3+ and CD3- clones with "lymphokine-activated killer" (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce interleukin-2.

Mingari MC, Ferrini S, Pende D, Bottino C, Prigione I, Moretta A, Moretta L. Mingari MC, et al. Among authors: pende d. Int J Cancer. 1987 Oct 15;40(4):495-8. doi: 10.1002/ijc.2910400411. Int J Cancer. 1987. PMID: 3117711

5

Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatinum (II) in vivo and in vitro.

Lichtenstein AK, Pende D. Lichtenstein AK, et al. Among authors: pende d. Cancer Res. 1986 Feb;46(2):639-44. Cancer Res. 1986. PMID: 3940633

6

Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells.

Ciccone E, Pende D, Vitale M, Nanni L, Di Donato C, Bottino C, Morelli L, Viale O, Amoroso A, Moretta A, et al. Ciccone E, et al. Among authors: pende d. Eur J Immunol. 1994 Apr;24(4):1003-6. doi: 10.1002/eji.1830240434. Eur J Immunol. 1994. PMID: 8149950

7

The molecular basis of natural killer (NK) cell recognition and function.

Moretta L, Mingari MC, Pende D, Bottino C, Biassoni R, Moretta A. Moretta L, et al. Among authors: pende d. J Clin Immunol. 1996 Sep;16(5):243-53. doi: 10.1007/BF01541388. J Clin Immunol. 1996. PMID: 8886992 Review.

8

The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.

Pende D, Accame L, Pareti L, Mazzocchi A, Moretta A, Parmiani G, Moretta L. Pende D, et al. Eur J Immunol. 1998 Aug;28(8):2384-94. doi: 10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L. Eur J Immunol. 1998. PMID: 9710216 Free article.

9

Human natural killer cell activating receptors.

Biassoni R, Cantoni C, Falco M, Pende D, Millo R, Moretta L, Bottino C, Moretta A. Biassoni R, et al. Among authors: pende d. Mol Immunol. 2000 Dec;37(17):1015-24. doi: 10.1016/s0161-5890(01)00018-9. Mol Immunol. 2000. PMID: 11399319 Review.

10

Human natural killer cell receptors and co-receptors.

Biassoni R, Cantoni C, Pende D, Sivori S, Parolini S, Vitale M, Bottino C, Moretta A. Biassoni R, et al. Among authors: pende d. Immunol Rev. 2001 Jun;181:203-14. doi: 10.1034/j.1600-065x.2001.1810117.x. Immunol Rev. 2001. PMID: 11513142 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters